Role of SIX5-mediated EXO1 overexpression in driving glioblastoma progression: Insights into tumor cell migration and angiogenesis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies the SIX5/EXO1 gene axis as crucial in glioblastoma multiforme (GBM) development. Targeting this axis shows promise for new GBM therapies.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Glioblastoma multiforme (GBM) is an aggressive brain tumor with high recurrence and treatment resistance.
- There is a critical need for novel, targeted therapeutic strategies against GBM.
Purpose Of The Study
- To investigate the roles of sine oculis homeobox homolog 5 (SIX5) and exonuclease 1 (EXO1) in GBM pathogenesis.
- To explore the SIX5/EXO1 axis as a potential therapeutic target for GBM.
Main Methods
- Bioinformatics analysis and experimental assays were employed.
- Gene expression, knockdown, overexpression, ChIP, and dual-luciferase reporter gene assays were performed.
- In vitro cell assays and in vivo xenograft models were utilized.
Main Results
- High expression of EXO1 was observed in GBM tissues.
- EXO1 knockdown suppressed GBM cell viability, proliferation, migration, invasion, and induced DNA fragmentation, hindering tumor growth.
- SIX5 was identified as an upstream regulator of EXO1, forming a critical SIX5/EXO1 axis.
- SIX5 downregulation inhibited GBM cell growth, partially reversed by EXO1 overexpression.
Conclusions
- The SIX5/EXO1 axis plays a critical role in driving GBM development.
- Targeting the SIX5/EXO1 interaction presents a potential therapeutic strategy for glioblastoma multiforme.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
